New Grant Awarded to USC for Study of Epigenetic Targets in Gastric Cancer
Research Roundup
As we continue our 2020 fundraising campaign, "Choose Hope," we are cheered by these recent research advances:

The FDA granted priority review to AstraZeneca’s and Daiichi Sankyo’s Enhertu in HER2-positive gastric cancer. In a clinical trial, the drug demonstrated a significant and meaningful improvement in objective response when compared to chemotherapy.

In a trial, Merck’s immunotherapy drug Keytruda was on par with chemotherapy in gastric cancer, with both extending overall survival by 11 months, but patients taking Keytruda experience far fewer side effects.

Researchers at the University of Arizona discovered a biomarker that appears in people before stomach cancer develops and that can be detected in blood tests. It’s a small non-coding RNA (microRNA) that’s produced by cells associated with the ulcer-causing bacteria Helicobacter pylori (H. pylori).
New Episode: Rice Cooking with a Little Help

Chef Hans shows how this very helpful - and musical - gadget can make it even easier to cook healthy, protein packed, and nutrient rich meals.

Have you tried one of Hans's recipes? Share it with us! Want more tips and meals? Find more episodes at the Gesundheit Kitchen on
Mark Your Calendar:
The Gesundheit Kitchen LIVESTREAM
Tuesday, November 24th, at noon PST
Streaming at and Facebook.
More Foundation Programs:
Special Thanks to Our
National Sustaining Sponsors
Spread the word. Share the Gastric Cancer Foundation Newsletter.